Related Experiment Video
Updated: Jun 2, 2026
Bacterial Expression and Purification of Human Matrix Metalloproteinase-3 using Affinity Chromatography
Published on: March 30, 2022
Status of research on matrix metalloproteinases (MMPs) in India
Introduction:
MMPs are extracellular matrix (ECM)-degrading enzymes that play a crucial role in embryogenesis, tissue remodeling, inflammation and angiogenesis. MMP-2 and -9 (also called type 2 and type 4 collagenase, or gelatinase A and B) are the key molecules that control invasion, tumor growth and metastasis. Tissue inhibitor of matrix metalloproteinase (TIMP) -2 and -1 are specific inhibitors of MMP-2 and MMP-9 respectively, and play a crucial role in regulation of MMP-2 and -9 activation, during pathophysiological processes. MMPs can specifically degrade native gelatin, collagens, fibronectin, ectactin and elastin. MMP-2 and -9 are overexpressed in almost all types of cancers, and so act as important therapeutic targets.
Areas Covered:
The status of MMP research in India from 1998 to 2010. In this review, the authors cover the role of matrix metalloproteinase inhibitors in cancer therapy.
Expert Opinion:
As compared with other parts of the world, Indian scientists have not generated a significant number of specific MMP inhibitors for the treatment of cancer, or other diseases. MMPs and membrane type (MT)-MMPs are potentially important therapeutic targets in many diseases, including cancers, therefore, designing specific inhibitors from natural products or through synthetic routes, is crucial.
Insights
Matrix metalloproteinases (MMPs) are crucial in cancer progression. Developing specific MMP inhibitors, particularly in India, is vital for effective cancer therapy and other diseases.
Area of Science:
- Biochemistry and Molecular Biology
- Oncology
- Drug Discovery
Background:
- Matrix metalloproteinases (MMPs) are enzymes degrading the extracellular matrix (ECM), essential in development, tissue repair, and cancer.
- MMP-2 and MMP-9 are key regulators of tumor invasion, growth, and metastasis.
- Tissue inhibitors of metalloproteinases (TIMPs) regulate MMP activity, crucial in disease pathogenesis.
Discussion:
- MMPs, particularly MMP-2 and MMP-9, are overexpressed in most cancers, presenting significant therapeutic targets.
- Research in India on MMP inhibitors for cancer therapy has been limited compared to global efforts.
- Designing specific inhibitors, either synthetically or from natural products, is critical for targeting MMPs and MT-MMPs.
Key Insights:
- MMPs play a critical role in cancer cell invasion, tumor growth, and metastasis.
- Specific MMP inhibitors are essential for cancer treatment.
- Indian scientists have a limited output of specific MMP inhibitors.
Outlook:
- Further research into novel synthetic or natural MMP inhibitors is crucial.
- Targeting MMPs and MT-MMPs holds promise for treating various diseases, including cancer.
- Increased focus on developing specific MMP inhibitors in India is needed.
